Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (661-670 of 831) with videos related to

Pageof 84
Sort By:
Brain : a Journal of Neurology|March 30, 2016
Corticosteroids compromise survival in glioblastomaKenneth L Pitter, Ilaria Tamagno, Kristina Alikhanyan, et al.
The Lancet. Oncology|August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect groupPhilipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
Journal of Neuro-Oncology|July 7, 2022
Mid-term treatment-related cognitive sequelae in glioma patientsSabine Schlömer, Jörg Felsberg, Milena Pertz, et al.
Neuro-Oncology|July 31, 2022
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumorsRoberta Rudà, David Capper, Adam D Waldman, et al.
Neuro-Oncology|November 5, 2019
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?Marijke B Coomans, Linda Dirven, Neil K Aaronson, et al.
Radiology|July 29, 2020
Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 TrialPhilipp Kickingereder, Gianluca Brugnara, Mikkel Bo Hansen, et al.
Neuro-Oncology|April 10, 2024
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO reviewLakshmi Nayak, Chetan Bettegowda, Florian Scherer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2021
Telomerase reverse transcriptase promoter mutation- and O<sup>6</sup>-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Neuro-Oncology Practice|December 11, 2020
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patientsMarijke B Coomans, Martin J B Taphoorn, Neil K Aaronson, et al.
Neuro-Oncology|August 2, 2022
Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader studyPhilipp Vollmuth, Martha Foltyn, Raymond Y Huang, et al.
Pageof 84

Showing results (661-670 of 831) with videos related to

Sort By:
Pageof 84
Brain : a Journal of Neurology|March 30, 2016
Corticosteroids compromise survival in glioblastomaKenneth L Pitter, Ilaria Tamagno, Kristina Alikhanyan, et al.
The Lancet. Oncology|August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect groupPhilipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
Journal of Neuro-Oncology|July 7, 2022
Mid-term treatment-related cognitive sequelae in glioma patientsSabine Schlömer, Jörg Felsberg, Milena Pertz, et al.
Neuro-Oncology|July 31, 2022
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumorsRoberta Rudà, David Capper, Adam D Waldman, et al.
Neuro-Oncology|November 5, 2019
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?Marijke B Coomans, Linda Dirven, Neil K Aaronson, et al.
Radiology|July 29, 2020
Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 TrialPhilipp Kickingereder, Gianluca Brugnara, Mikkel Bo Hansen, et al.
Neuro-Oncology|April 10, 2024
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO reviewLakshmi Nayak, Chetan Bettegowda, Florian Scherer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2021
Telomerase reverse transcriptase promoter mutation- and O<sup>6</sup>-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Neuro-Oncology Practice|December 11, 2020
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patientsMarijke B Coomans, Martin J B Taphoorn, Neil K Aaronson, et al.
Neuro-Oncology|August 2, 2022
Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader studyPhilipp Vollmuth, Martha Foltyn, Raymond Y Huang, et al.
Pageof 84